Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Kite Pharma Inc (NASDAQ:KITE)

128.09
Delayed Data
As of 4:00pm ET
 +1.29 / +1.02%
Today’s Change
39.82
Today|||52-Week Range
130.10
+185.66%
Year-to-Date

Today’s Trading

Previous close126.80
Today’s open126.51
Day’s range124.22 - 129.20
Volume922,596
Average volume (3 months)1,170,531
Market cap$7.3B
Dividend yield--
Data as of 4:00pm ET, 08/16/2017

Growth & Valuation

Earnings growth (last year)-134.33%
Earnings growth (this year)-49.85%
Earnings growth (next 5 years)--
Revenue growth (last year)+28.46%
P/E ratioNM
Price/Sales98.98
Price/Book14.84

Competitors

 Today’s
change
Today’s
% change
BIVVBioverativ Inc-0.03-0.05%
NBIXNeurocrine Bioscienc...-0.49-0.91%
EXASExact Sciences Corp-0.38-0.97%
BLUEbluebird bio Inc+0.05+0.05%
Data as of 4:00pm ET, 08/16/2017

Financials

Last reporting dateAugust 8, 2017
EPS forecast (this quarter)-$1.98
Annual revenue (last year)$22.2M
Annual profit (last year)-$267.1M
Net profit margin-1,204.65%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Arie S. Belldegrun
Chief Operating Officer
Cynthia M. Butitta
Corporate headquarters
Santa Monica, California

Forecasts